Get started
Author

Héctor Pallarés Manrique

Observed names: H Pallares Manrique, H Pallarés Manrique, H Pallarés-Manrique, H. Pallares Manrique, H. Pallarés Manrique, H. Pallarés Manrrique, H. Pallarés-Manrique, Hector Pallares Manrique, Hector Pallares-Manrique, Héctor Pallares Manrique, Héctor Pallarés-Manrique
ORCID: 0000-0003-0863-4465
Observed ORCID: 0000-0003-0863-4465
OpenAlex ID: A5000217245
Prevalence of Primary Resistance of Helicobacter pylori to Clarithromycin and Levofloxacin in Southern Spain
2015 · José María Navarro-Jarabo, Fernando Fernández-Sánchez, et al. · Digestion · 42
Crohn's-like disease in a patient with common variable immunodeficiency treated with azathioprine and adalimumab
2013 · Juan María Vázquez-Morón, Héctor Pallarés-Manrique, et al. · Revista Española de Enfermedades Digestivas · 30
PDF
Prognosis of Patients with Ulcerative Colitis in Sustained Remission After Thiopurines Withdrawal
2015 · Estefanía Moreno-Rincón, José Manuel Benítez, et al. · Inflammatory Bowel Diseases · 28
Automatic detection of crohn disease in wireless capsule endoscopic images using a deep convolutional neural network
2022 · Diego Marin-Santos, Juan A. Contreras-Fernandez, et al. · Applied Intelligence · 24
Accurate cut-offs for predicting endoscopic activity and mucosal healing in Crohn’s disease with fecal calprotectin
2017 · Juan María Vázquez Morón, Héctor Pallarés Manrique, et al. · Revista Española de Enfermedades Digestivas · 22
The onset of ulcerative colitis during treatment with secukinumab: can anti-IL-17A be a trigger for inflammatory bowel disease?
2019 · Rafael Rodríguez Moncada, Juan María Vázquez Morón, et al. · Revista Española de Enfermedades Digestivas · 20
Ustekinumab in Crohn's disease: real-world outcomes and predictors of response.
2020 · Laura Lorenzo González, Teresa Valdés Delgado, et al. · Revista Española de Enfermedades Digestivas · 18
PDF
Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: results of a multicenter study after 12 months
2018 · María Fernanda Guerra Veloz, Juan María Vázquez Morón, et al. · Revista Española de Enfermedades Digestivas · 18
Initial experience with golimumab in clinical practice for ulcerative colitis
2016 · Luisa Castro Laria, Federico Argüelles Arias, et al. · Revista Española de Enfermedades Digestivas · 18
Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial
2019 · María Chaparro, María G. Donday, et al. · Therapeutic Advances in Gastroenterology · 7
Intermittent small bowel obstruction secondary to enterolithiasis in Crohn's disease
2009 · A. Bejarano García, H. Pallarés Manrique, et al. · Revista Española de Enfermedades Digestivas · 6
PDF
Intravenous ustekinumab reinduction as a Crohn�s disease rescue strategy following a secondary non-response
2019 · Juan María Vázquez Morón, Rafael Rodríguez Moncada, et al. · Revista Española de Enfermedades Digestivas · 5
Long-term clinical outcomes with filgotinib in ulcerative colitis: 12-month results from the FILGUITO study
2026 · Antonio M Caballero-Mateos, Claudio Trigo-Salado, et al. · World Journal of Gastroenterology · 3
PDF
P319 Accurate cut-offs for predicting endoscopic activity and mucosal healing in Crohn's disease with fecal calprotectin
2017 · J.M. Vázquez-Morόn, B. Benítez-Rodríguez, et al. · Journal of Crohn s and Colitis · 3
P762 Onset of inflammatory bowel disease during treatment with secukinumab: Can anti-IL-17A be a trigger for inflammatory bowel disease?
2019 · R Rodríguez Moncada, J M Vázquez Morón, et al. · Journal of Crohn s and Colitis · 2
Hemorragia digestiva secundaria a tumor del estroma gastrointestinal en dos pacientes con neurofibromatosis
2009 · A. Bejarano García, M. Rojas Feria, et al. · Revista Española de Enfermedades Digestivas · 2
PDF
P519 Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: Multicentre study at 12 months results
2018 · M F Guerra Veloz, M Belvis Jimenez, et al. · Journal of Crohn s and Colitis · 1
P693 Patients with inflammatory bowel disease who are on immunosuppressive therapy perform regular gynecologic screening for uterine cervical cancer?
2017 · J.M. Vázquez-Morόn, A. Cabello Fernández, et al. · Journal of Crohn s and Colitis · 1
Utilidad de la calprotectina fecal en la enfermedad inflamatoria intestinal
2017 · Juan María Vázquez Morón, Federico Argüelles‐Arias, et al. · Deposito de Investigacion Universidad de Sevilla (University of Seville) · 1
Íleo biliar en paciente de edad avanzada
2008 · R. Pozo Moreno, M. Rojas Feria, et al. · Revista Española de Enfermedades Digestivas · 1
PDF
Ulcerative colitis, but not Crohn’s disease, displays demographically and clinically driven mucosal immune heterogeneity: implications for patient stratification
2026 · Ángel De Prado, Irene Soleto, et al. · Frontiers in Immunology
PDF
From universal biomarkers to individualized trajectory-based profiles: charting the multi-omic future of precision medicine in IBD
2026 · Dimitrios Kioroglou, Montse Baldán-Martín, et al. · Research Square
PDF
Calprotectina Fecal Como Predictor De Brote En Proctitis Ulcerosa: Resultados De Un Estudio Prospectivo Multicéntrico
2026 · Rocío Ferreiro-Iglesias, Laura Nieto García, et al. · Gastroenterología y Hepatología
30 - Identificados Perfiles Metabólicos-lipoproteicos En Suero Y Orina Predictores De Respuesta a Biológicos E Inhibidores De Jak En La Enfermedad Inflamatoria Intestinal
2026 · Paula J. Martínez, Montse Baldán-Martín, et al. · Gastroenterología y Hepatología
P1160 Filgotinib in Biologic-Experienced Ulcerative Colitis: One-Year Real-World Results from the FILGUITO Study
2026 · A M Caballero Mateos, C Trigo Salado, et al. · Journal of Crohn s and Colitis
Works count: 49
Citation count: 252
H-index: 9
I10-index: 9
Year
Topic
Type